Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Erytech Pharma. (12/7/15). "Press Release: Erytech Raises Approximately €25.4 Million in a Private Placement". 2015-12-07
Eurofins Scientific. (12/3/15). "Press Release: Eurofins Expands into Hygiene Testing in Hospitals with the Acquisition of Biotech-Germande". 2015-12-03
TxCell S.A.. (12/2/15). "Press Release: TxCell Re-acquires Full Rights to Its Lead Product Ovasave. Agreement between TxCell and Trizell to Terminate the Exclusive Option". Valbonne. 2015-12-02
Carbios S.A.. (12/2/15). "Press Release: Carbios Depolymerizes 100% of PET based Plastic Waste with its Enzymatic Recycling Process. A Unique Technology Paving the Way to Infinite Recycling of PET". Clermont-Ferrand. 2015-12-02
MedDay Pharmaceuticals S.A.S.. (12/1/15). "Press Release: MedDay Provides Update on MS-ON Study of MD-1003". Paris. 2015-12-01
Neovacs S.A.. (12/1/15). "Press Release: Neovacs Announces Its Engagement in the Field of Immunotherapy in Cancer, Following the Recommendation of Its Scientific Advisory Board which Met in New York on the 17th of November". Paris & Boston, MA. 2015-12-01
ImaBiotech S.A.S.. (12/1/15). "Press Release: ImaBiotech’s Multimaging Technology Chosen by Dermira for Its Skin Disposition Study". Lille. 2015-12-01
TxCell S.A.. (11/30/15). "Press Release: TxCell Strengthens Management Team with Five New Vice Presidential Appointments". Valbonne. 2015-11-30
BioCellChallenge S.A.S.. (11/30/15). "Press Release: BioCellChallenge Obtains Unprecedented In-vivo Results Using Intracellular Delivery Technology for Therapeutic Antibodies". Toulon. 2015-11-30
Cellectis S.A.. (11/30/15). "Press Release: Cellectis Announces Presentations at Upcoming Conferences". New York. 2015-11-30
Toulouse White Biotech (TWB). (11/26/15). "Press Release: TWB Announces the Creation of EnobraQ, Specialist in CO2 Capture and Exploitation Using Yeast". Toulouse & Paris. 2015-11-26
Magnisense SE. (11/24/15). "Press Release: Magnisense Raises €5.5 Million to Better Diagnose Cardiovascular Diseases • New shareholders join the company". Paris. 2015-11-24
Ipsen S.A.. (11/19/15). "Press Release: Ipsen and Interprotein Enter into a Research Collaboration for Novel Peptides in Endocrinology". Paris & Osaka. 2015-11-19
Genfit S.A.. (11/16/15). "Press Release: Genfit Announces Pivotal Phase 3 Clinical Trial of Elafibranor in NASH Following Regulatory Input". Lille & Cambridge, MA. 2015-11-16
Catalent. (11/16/15). "Press Release: Catalent Working to Re-start Production at French Facility". 2015-11-16
Sofinnova Partners. (11/16/15). "Press Release: Sofinnova Launches BiovelocITA – the First Biotech Accelerator in Italy". Milan. 2015-11-16
Pierre Fabre S.A.. (11/16/15). "Press Release: Array BioPharma and Pierre Fabre Announce Development and Commericalization Collaboration for Two Novel Oncology Products, Binimetinib and Encorafenib". Boulder, CO. 2015-11-16
Enterome Bioscience S.A.. (11/12/15). "Press Release: Enterome and Gustave Roussy Enter into a Microbiome-based Collaboration to Develop Novel Immunotherapy Solutions to Treat Cancer". 2015-11-12
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
ImaBiotech S.A.S.. (11/10/15). "Press Release: Galderma and ImaBiotech Develop a Long-term Alliance to Access Multimaging Services". Lille & Sophia Antipolis. 2015-11-10
Novasep S.A.. (11/10/15). "Press Release: Novasep and CPI Advance Innovation in UK Biopharmaceutical Manufacturing". Pompey. 2015-11-10
Valneva S.E.. (11/10/15). "Press Release: Valneva Reports a Strong Quarter Marked by Key Successes in its Strategic Execution and a Solid Financial Performance". Lyon. 2015-11-10
Pierre Fabre S.A.. (11/10/15). "Press Release: Pierre Fabre – a New Partner in the UNICANCER ESME Program". 2015-11-10
Pierre Fabre S.A.. (11/10/15). "Press Release: The Swiss Federal Institute of Technology in Lausanne (EPFL) and Pierre Fabre Médicament (PFM) Join Forces to Study the Use of Biosensor Chips in the Clinical Development of Drugs". Castres. 2015-11-10
Sanofi S.A.. (11/6/15). "Press Release: Sanofi Sets Out Strategic Roadmap for Long-term Growth". Paris. 2015-11-06
Sanofi S.A.. (11/6/15). "Press Release: Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes". Paris & The Woodlands, TX. 2015-11-06
TxCell S.A.. (11/5/15). "Press Release: Financial Information for the 3rd Quarter of 2015". Valbonne. 2015-11-05
Sanofi S.A.. (11/5/15). "Press Release: Sanofi and Hanmi Announce License Agreement to Develop Portfolio of Long-acting Diabetes Treatments". Paris & Seoul. 2015-11-05
LFB S.A.. (11/5/15). "Press Release: Movements within the LFB Group". Les Ulis. 2015-11-05
bioMérieux S.A.. (11/4/15). "Press Release: bioMérieux Introduces GENE-UP, a New Molecular Diagnostic Solution for Food Pathogen Detection Jointly Developed with BioFire". Marcy l’Étoile. 2015-11-04
ElsaLys Biotech S.A.S.. (11/3/15). "Press Release: ElsaLys Biotech Announces the Completion of the First Instalment of a Total Fundraising amounting to € 5 Million". Lyon & Ilkirch-Graffenstaden. 2015-11-03
Pierre Fabre S.A.. (11/2/15). "Press Release: Pierre Fabre Joins the IQ Consortium, an Organization Bringing together Pharmaceutical and Biotech Companies from All Over the World". Castres. 2015-11-02
TxCell S.A.. (11/2/15). "Press Release: TxCell Secures Key CAR-Treg Patent through Exclusive Option Agreement with Yeda, the Commercial Arm of World’s Recognized Weizmann Institute of Science". Frankfurt a. M.. 2015-11-02
Neovacs S.A.. (10/28/15). "Press Release: Neovacs Announces Its Participation in Upcoming Investor Conferences". Paris & Boston, MA. 2015-10-28
bioMérieux S.A.. (10/22/15). "Press Release: Business Review for the Nine Months Ended September 30, 2015". Marcy l’Étoile. 2015-10-22
Hybrigenics S.A.. (10/19/15). "Press Release: Hybrigenics 2015 First-half Results and Highlights. Stable Turnover at EUR 1.9 Million – Net Loss Contained at EUR 2.3 Million". Paris. 2015-10-19
TxCell S.A.. (10/14/15). "Press Release: TxCell Reviews Its Manufacturing Strategy to Focus on R&D and Strategic Partnerships – Its Core, High Added Value Businesses". Valbonne. 2015-10-14
Biomunex Pharmaceuticals SASU. (10/13/15). "Press Release: Biomunex Appoints Dr. Eugene Zhukovsky as CSO". Paris. 2015-10-13
LFB S.A.. (10/12/15). "Press Release: LFB S.A. Increases Its Capital by 230 Million Euros". Les Ulis. 2015-10-12
Deinove S.A.. (10/9/15). "Press Release: Dennis McGrew Joins Deinove Executive Committee as Chief Business Officer". 2015-10-09
MedDay Pharmaceuticals S.A.S.. (10/7/15). "Press Release: MedDay Reports Additional Positive Analyses of Its Pivotal Study with MD1003 in Patients with Primary and Secondary Progressive Multiple Sclerosis". Paris. 2015-10-07
[iito] Business Intelligence. (10/5/15). "Press Release: Launches Today. New Business Web Portal for the French Life Sciences Targets Decision Makers Worldwide". Bremen & Paris. 2015-10-05
Servier. (10/5/15). "Press Release: Servier Offers Its Expertise in Industrial R&D, Chemical Synthesis and Pharmaceutical Manufacturing to Partners". 2015-10-05
Therachon. (9/29/15). "Press Release: Therachon Secures $35 Million Financing". Nice. 2015-09-29
Novasep S.A.. (9/29/15). "Press Release: Novasep Appoints World-class Scientists to Strengthen Its Advisory Board". Pompey. 2015-09-29
Enterome Bioscience S.A.. (9/29/15). "Press Release: Georges Gemayel Appointed Non-executive Chairman of Enterome". Paris. 2015-09-29
Innate Pharma S.A.. (9/28/15). "Press Release: First Patient Treated in Phase I/II Trial with IPH2201 in Ovarian Cancer". Marseille. 2015-09-28
Erytech Pharma. (9/28/15). "Press Release: Erytech Provides Business Update and Financial Results for the First Half of 2015". Lyon. 2015-09-28
Sanofi S.A.. (9/28/15). "Press Release: Sanofi and Regeneron Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in the European Union". Paris & Tarrytown, NY. 2015-09-28
Sanofi S.A.. (9/28/15). "Press Release: Sanofi Reaches Patent Settlement on Lantus SoloSTAR". Paris. 2015-09-28
Stentys S.A.. (9/28/15). "Press Release: Stentys Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease". Princeton, N.J. & Paris. 2015-09-28
TxCell S.A.. (9/28/15). "Press Release: TxCell to Present Its Cellular Immunotherapy Developments at Leading Investor Conferences". Valbonne. 2015-09-28
Servier. (9/24/15). "Press Release: Servier and Nerviano Medical Sciences Announce the Entry of S 81694, an MPS1 inhibitor, in a first in Human Clinical Trial". Suresnes & Nerviano. 2015-09-24
TxCell S.A.. (9/22/15). "Press Release: Financial Results for the First Half of 2015". Valbonne. 2015-09-22
Genticel S.A.. (9/21/15). "Press Release: Genticel Presents First Half 2015 Financial Results, Operational Progress and Outlook". 2015-09-21
AB Science S.A.. (9/21/15). "Press Release: AB Science Announces Cessation of Its Rheumatoid Arthritis Study in Order to Focus on Clinical Studies with a Probability of Success Greater than 50%". Paris. 2015-09-21
Innate Pharma S.A.. (9/17/15). "Press Release: First Half of 2015. Landmark Agreement with AstraZeneca and Strong Financial Position". 2015-09-17
MaaT Pharma. (9/17/15). "Press Release: MaaT Pharma Awarded for Its Microbiota Therapy for Severe Gut Dysbioses at French Worldwide Innovation Challenge". Lyon. 2015-09-17
AB Science S.A.. (9/16/15). "Press Release: Masitinib Receives Orphan Drug Designation for Stomach Cancer from FDA". Paris. 2015-09-16
Abivax S.A.. (9/15/15). "Press Release: Abivax Appoints Antonino Ligresti, MD and Dominique Costantini, MD to its Board of Directors". Paris. 2015-09-15
Sanofi S.A.. (9/15/15). "Press Release: Sanofi Successfully Prices EUR 2.0 Billion Bond Issue". Paris. 2015-09-15
Neovacs S.A.. (9/9/15). "Press Release: Neovacs Confirms Potent and Long-lasting Biological Activity of IFNa-Kinoid 4 Years after Patient Dosing in Phase I/IIa Trial". Paris & Boston, MA. 2015-09-09
Pherecydes Pharma. (9/9/15). "Press Release: A World First. Pherecydes Pharma Launches Multicenter Clinical Study of Phage Therapy in Serious Burn Victims". Romainville. 2015-09-09
Ares Allergy Holdings plc. (9/8/15). "Press Release: Combination of Stallergenes and Greer Laboratories – Creation of the Global Leader in Allergy Immunotherapy [Not for ZA, AU, CA, JP, NZ or US]". London. 2015-09-08
Euronext N.V.. (9/8/15). "Press Release: New Stallergenes Greer Entity Lists Successfully on Euronext Paris". Paris. 2015-09-08
Genticel S.A.. (9/8/15). "Press Release: US Patent Granted for Use of Genticel’s Antigen Delivery Vectors in Combination Therapy to Treat Cancer". Paris & Toulouse. 2015-09-08
Innate Pharma S.A.. (9/7/15). "Press Release: Upcoming Investor Conferences". 2015-09-07
Cellectis S.A.. (9/3/15). "Press Release: MD Anderson Cancer Center and Cellectis Announce a Broad Preclinical and Clinical Strategic Alliance in Cancer Immunotherapy". New York, NY. 2015-09-03
DBV Technologies. (9/3/15). "Press Release: DBV Technologies to Attend Upcoming Investor Conferences and Events". Bagneux. 2015-09-03
Deinove S.A.. (9/2/15). "Press Release: Deinove Produces Muconic Acid from 2G Substrates. Proof of Concept Has Been Obtained with Second-generation Materials ". Montpellier. 2015-09-02
Neovacs S.A.. (9/1/15). "Press Release: Neovacs Receives First Regulatory Approvals for a Phase IIb Trial of IFNalpha-Kinoid in Lupus. IFN-K-002 Clinical Trial to Launch in Coming Weeks". Paris & Boston, MA. 2015-09-01
Erytech Pharma. (9/1/15). "Press Release: Erytech Appoints Eric Soyer as Chief Financial and Chief Operating Officer". Lyon. 2015-09-01
OSE Pharma S.A.. (9/1/15). "Press Release: OSE Pharma Sets Up Scientific Steering Committee and Takes a First Step in the Launch of Its Phase 3 Trial in Lung Cancer [Not for US, CA, AU or JP]". Paris. 2015-09-01
Genticel S.A.. (9/1/15). "Press Release: Genticel to Meet Investors". Paris & Toulouse. 2015-09-01
Sanofi S.A.. (8/31/15). "Press Release: Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes". Paris & Mountain View, CA. 2015-08-31
AB Science S.A.. (8/31/15). "Press Release: Turnover of 1,260K€ in the First Half of 2015, Up 23% when Compared with the First Half of 2014". Paris. 2015-08-31
bioMérieux S.A.. (8/31/15). "Press Release: bioMérieux – First-Half 2015 Results". 2015-08-31
Valneva S.E.. (8/27/15). "Press Release: Valneva Announces Two New EB66 Agreements. 7 new EB66 Deals Signed Since the Beginning of the Year". Lyon. 2015-08-27
TxCell S.A.. (8/24/15). "Press Release: TxCell Consortium Granted €1.28 Million for TRUST Project on Process and Clinical Development of Col-Treg for Autoimmune Uveitis Treatment". Valbonne. 2015-08-24
Hybrigenics S.A.. (8/10/15). "Press Release: Hybrigenics’ Inecalcitol Gets Orphan Drug Designation for the Treatment of Acute Myeloid Leukemia in the United States". Paris. 2015-08-10
Sanofi S.A.. (8/7/15). "Press Release: Sanofi, Evotec Enter New Research Collaboration to Discover and Develop Novel Diabetes Therapies". Paris. 2015-08-07
Novacyt S.A.. (8/4/15). "Press Release: Novacyt Secures Further Funding of up to 5 Millon Euros". Paris & Cambridge. 2015-08-04
Biophytis S.A.. (8/4/15). "Press Release: Biophytis Successfully Raises €6 million in a Private Placement to Secure Its Development Strategy [Not for distribution in the United States, Canada, Japan or Australia]". Romainville. 2015-08-04
Sanofi S.A.. (7/30/15). "Press Release: Sanofi Delivers Solid Sales and Business EPS Growth in Q2 2015". Paris. 2015-07-30
Sanofi S.A.. (7/29/15). "Press Release: Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint". Paris. 2015-07-29
Sanofi S.A.. (7/28/15). "Press Release: Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration. Companies Agree to Jointly Advance PD-1 and other New Immuno-oncology Antibodies". Paris & Tarrytown, NY. 2015-07-28
Sanofi S.A.. (7/24/15). "Press Release: Sanofi and Regeneron Announce FDA Approval of Praluent (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients". Paris & Tarrytown, NY. 2015-07-24
Sanofi S.A.. (7/24/15). "Press Release: Sanofi and Regeneron Announce CHMP Recommends European Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia". Paris & Tarrytown, NY. 2015-07-24
MaaT Pharma. (7/24/15). "Press Release: MaaT Pharma Accelerates Its Development with the Closing of EUR 1 M in Second Fundraising Important step in developing microbiome therapy for severe intestinal dysbiosis". Lyon. 2015-07-24
Poxel S.A.. (7/24/15). "Press Release: Poxel Raises EUR 20 Million in a Private Placement Led by Leading US Healthcare Investors [Not for distribution in the United States, Canada, Japan or Australia]". Lyon. 2015-07-24
GenSight Biologics S.A.. (7/23/15). "Press Release: GenSight Biologics Closes $36 Million Series B Preferred Stock Financing". Paris. 2015-07-23
Valneva S.E.. (7/23/15). "Press Release: Valneva and PaxVax Enter into Marketing and Distribution Agreement". Lyon. 2015-07-23
CEA-Leti. (7/22/15). "Press Release: Leti and Diabeloop Project Aim at Developing Artificial Pancreas for Diabetes Treatment". Grenoble & Evry. 2015-07-22
Sartorius AG. (7/21/15). "Press Release: First Half of 2015. Sartorius Stedim Biotech Continues Dynamic Growth". 2015-07-21
DBV Technologies. (7/20/15). "Press Release: DBV Technologies Announces Closing of $281.5 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Bagneux. 2015-07-20
Novacyt S.A.. (7/20/15). "Press Release: Novacyt Completes €2m Private Placement to Support Second Half Sales Growth". Paris & Cambridge. 2015-07-20
Novacyt S.A.. (7/20/15). "Press Release: Strong First-half Revenues. Completes €3.5m in Bond Refinancing and Launches a €1.7m Private Placement". Paris & Cambridge. 2015-07-20
Arbiom Inc.. (7/16/15). "Press Release: OptaFuel and Biométhodes Combine to Form Arbiom". 2015-07-16
Cellectis S.A.. (7/8/15). "Press Release: Cellectis Reaches Milestone in Servier Collaboration". New York, NY. 2015-07-08
Seventure Partners. (7/8/15). "Press Release: Seventure Partners Invests EUR 2 Million in CRISPR-based, Microbiome Company, Eligo Bioscience". Paris. 2015-07-08
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSG] – The Business Web Portal 600x80px

» top